拉波特治疗

最新新闻

• 公司公告
  CrossFirst Bankshares | 4: Statement of changes in beneficial ownership of securities-Officer Rapp W. Randall
  SEC · 2025/2/27
• 评级变动
  Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and The Estée Lauder Companies (EL)
  TipRanks · 2026/9/24
• 评级变动
  Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and Micron (MU)
  TipRanks · 2026/9/23
• 评级变动
  A Quick Look at Today's Ratings for Rapport Therapeutics(RAPP.US), With a Forecast Between $50 to $75
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 公司公告
  CrossFirst Bankshares(Delisted) | 4: Statement of changes in beneficial ownership of securities-Officer Rapp W. Randall
  SEC · 2025/3/5
• 评级变动
  JonesTrading Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $50
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• Analysts Offer Insights on NA Companies: Andersen Group, Inc. Class A (ANDG) and Rapport Therapeutics, Inc. (RAPP)
  TipRanks · 2026/9/23
• Rapport Therapeutics, Inc. (RAPP) Receives a Buy From TD Cowen
  TipRanks · 2026/9/23
• 评级变动
  Analysts Conflicted on These NA Names: Rapport Therapeutics, Inc. (RAPP), Idexx Laboratories (IDXX) and Waystar Holding Corp. (WAY)
  TipRanks · 2026/9/16
• 评级变动
  Analysts Are Bullish on Top NA Stocks: Rapport Therapeutics, Inc. (RAPP), Paymentus Holdings (PAY)
  TipRanks · 2026/9/15
• 评级变动
  Analysts Offer Insights on NA Companies: Jack Henry & Associates (JKHY) and Rapport Therapeutics, Inc. (RAPP)
  TipRanks · 2026/9/16
• 公司公告
  The Bank of Princeton | 4: Statement of changes in beneficial ownership of securities-Officer Rapp George S.
  SEC · 2026/1/27
• 公司公告
  The Bank of Princeton | 4: Statement of changes in beneficial ownership of securities-Officer Rapp George S.
  SEC · 2026/2/11
• BTIG Keeps Their Buy Rating on Rapport Therapeutics, Inc. (RAPP)
  TipRanks · 2026/10/2
• 公司公告
  The Bank of Princeton | 4: Statement of changes in beneficial ownership of securities-Officer Rapp George S.
  SEC · 2026/1/23
• 评级变动
  Truist Financial Maintains Rapport Therapeutics(RAPP.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/15
• 评级变动
  Analysts Conflicted on These NA Names: General Dynamics (GD), Rapport Therapeutics, Inc. (RAPP) and First Solar (FSLR)
  TipRanks · 2026/9/23
• A Quick Look at Today's Ratings for Rapport Therapeutics(RAPP.US), With a Forecast Between $66 to $66
  \u5e02\u573a\u8d44\u8baf · 2026/9/24
• BTIG Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $75
  \u5e02\u573a\u8d44\u8baf · 2026/10/2
• 评级变动
  A Quick Look at Today's Ratings for Rapport Therapeutics(RAPP.US), With a Forecast Between $66 to $75
  \u5e02\u573a\u8d44\u8baf · 2026/9/23

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。